DK1096952T3 - Polysaccharidvaccine mod stafylokok-infektioner - Google Patents

Polysaccharidvaccine mod stafylokok-infektioner

Info

Publication number
DK1096952T3
DK1096952T3 DK99934091T DK99934091T DK1096952T3 DK 1096952 T3 DK1096952 T3 DK 1096952T3 DK 99934091 T DK99934091 T DK 99934091T DK 99934091 T DK99934091 T DK 99934091T DK 1096952 T3 DK1096952 T3 DK 1096952T3
Authority
DK
Denmark
Prior art keywords
vaccine against
polysaccharide vaccine
staphylococcal infections
infections
against staphylococcal
Prior art date
Application number
DK99934091T
Other languages
English (en)
Inventor
Gerald B Pier
David Mckenney
Ying Wang
Original Assignee
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham & Womens Hospital filed Critical Brigham & Womens Hospital
Application granted granted Critical
Publication of DK1096952T3 publication Critical patent/DK1096952T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK99934091T 1998-07-15 1999-07-15 Polysaccharidvaccine mod stafylokok-infektioner DK1096952T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9311798P 1998-07-15 1998-07-15
PCT/US1999/016129 WO2000003745A2 (en) 1998-07-15 1999-07-15 Polysaccharide vaccine for staphylococcal infections

Publications (1)

Publication Number Publication Date
DK1096952T3 true DK1096952T3 (da) 2008-08-25

Family

ID=22237266

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99934091T DK1096952T3 (da) 1998-07-15 1999-07-15 Polysaccharidvaccine mod stafylokok-infektioner

Country Status (11)

Country Link
EP (2) EP1967203A1 (da)
JP (1) JP5490341B2 (da)
AT (1) ATE395931T1 (da)
AU (1) AU771563C (da)
CA (1) CA2333931C (da)
CY (1) CY1108542T1 (da)
DE (1) DE69938784D1 (da)
DK (1) DK1096952T3 (da)
ES (1) ES2308844T3 (da)
PT (1) PT1096952E (da)
WO (1) WO2000003745A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
CA2434546C (en) * 2001-01-12 2012-09-11 Chiron Corporation Induction of immune response by a replication-defective venezuelan equine encephalitis-sindbis chimeric virus replicon particle encoding an antigen
WO2003053462A2 (en) * 2001-12-11 2003-07-03 Merck & Co., Inc. Staphylococcus aureus exopolysaccharide and process
US20060210555A1 (en) 2001-12-21 2006-09-21 Antigenics, Inc. Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
AU2003290867A1 (en) 2002-11-12 2004-06-03 The Brigham And Women's Hospital, Inc. Methods and products for treating staphylococcal infections
PL229487B1 (pl) 2002-11-12 2018-07-31 Brigham & Womens Hospital Inc Kompozycja zawierająca polimer β-1,6-glukozaminy, kompozycja zawierająca przeciwciało, kompozycja farmaceutyczna, sposób wytwarzania wyodrębnionego polisacharydu, sposób identyfikacji obecności deacetylowanej poli-N-acetyloglukozaminy (dPNAG) i/ lub poli-N-acetyloglukozaminy (PNAG), wyodrębniony polisacharyd do zastosowania w leczeniu lub profilaktyce zakażenia, wyodrębniony polisacharyd do zastosowania do wytwarzania przeciwciał, w tym przeciwciał monoklonalnych, wyodrębniony polisacharyd do zastosowania w identyfikacji przeciwciała monoklonalnego
AU2014277807B2 (en) * 2004-04-21 2017-05-25 Beth Israel Deaconess Medical Center, Inc. Poly-N-acetyl glucosamine(PNAG/DPNAG)-binding peptides and methods of use thereof
ES2415358T3 (es) * 2004-04-21 2013-07-25 The Brigham And Women's Hospital, Inc. Péptidos de fijación a la poli-N-acetil glucosamina (PNAG/DPNAG) y procedimientos para el uso de los mismos
AU2012205180B2 (en) * 2004-04-21 2014-10-09 Beth Israel Deaconess Medical Center, Inc. Poly-N-acetyl glucosamine(PNAG/DPNAG)-binding peptides and methods of use thereof
NZ553776A (en) * 2004-09-22 2010-05-28 Glaxosmithkline Biolog Sa Immunogenic composition comprising staphylococcal PNAG and Type 5 and/or 8 Capsular polysaccharide or oligosaccharide.
RU2419628C2 (ru) * 2004-09-22 2011-05-27 ГлаксоСмитКлайн Байолоджикалз с.а. Иммуногенная композиция для применения в вакцинации против стафилококков
EP2476433A1 (en) * 2006-03-30 2012-07-18 GlaxoSmithKline Biologicals S.A. Immunogenic composition
CN102159540B (zh) 2008-07-21 2015-08-12 布赖汉姆妇女医院 与合成的β-1,6葡糖胺寡糖相关的方法和组合物
US12397014B2 (en) 2019-02-05 2025-08-26 The Brigham And Women's Hospital, Inc. Polysaccharide compositions for use in treating filariasis
US10828360B1 (en) * 2020-02-04 2020-11-10 OneBioPharma, Inc. Methods for inhibiting biofilm formation

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
FR2046920B1 (da) 1969-06-19 1974-05-03 Citizen Watch Co Ltd
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
US3832253A (en) 1973-03-21 1974-08-27 Baxter Laboratories Inc Method of making an inflatable balloon catheter
US4355023A (en) 1980-09-30 1982-10-19 The Massachusetts General Hospital Antibody fragment compositions and process
US4356170A (en) 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US4470925A (en) 1982-05-05 1984-09-11 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
US4667014A (en) 1983-03-07 1987-05-19 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
US4619828A (en) 1982-07-06 1986-10-28 Connaught Laboratories, Inc. Polysaccharide exotoxoid conjugate vaccines
US4462334A (en) 1982-08-19 1984-07-31 Kim Ho K Solar animal structure
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
US4663160A (en) 1983-03-14 1987-05-05 Miles Laboratories, Inc. Vaccines for gram-negative bacteria
CA1200416A (en) 1983-05-13 1986-02-11 Societe Des Produits Nestle S.A. Food process
US4808700A (en) 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
IT1187753B (it) 1985-07-05 1987-12-23 Sclavo Spa Coniugati glicoproteici ad attivita' immunogenica trivalente
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5567610A (en) 1986-09-04 1996-10-22 Bioinvent International Ab Method of producing human monoclonal antibodies and kit therefor
US5565354A (en) 1986-09-05 1996-10-15 Sandoz Ltd. Production of human monoclonal antibodies specific for hepatitis B surface antigen
FR2619122B1 (fr) * 1987-08-03 1990-03-09 Pasteur Institut Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede
US5055455A (en) * 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
FR2640628A1 (fr) * 1988-12-16 1990-06-22 Commissariat Energie Atomique Oligosaccharides lies (beta)-(1 -> 6) en particulier des 2-acetamido-2-desoxy-glucoses ou - galactoses et leur preparation
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
JPH04167172A (ja) 1990-10-31 1992-06-15 Nec Corp ベクトルプロセッサ
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor

Also Published As

Publication number Publication date
ES2308844T3 (es) 2008-12-01
DE69938784D1 (de) 2008-07-03
AU771563C (en) 2004-10-28
JP5490341B2 (ja) 2014-05-14
AU771563B2 (en) 2004-03-25
EP1096952B1 (en) 2008-05-21
CY1108542T1 (el) 2014-04-09
CA2333931C (en) 2013-09-03
AU5000199A (en) 2000-02-07
ATE395931T1 (de) 2008-06-15
EP1967203A1 (en) 2008-09-10
EP1096952A2 (en) 2001-05-09
CA2333931A1 (en) 2000-01-27
PT1096952E (pt) 2008-08-27
JP2002520374A (ja) 2002-07-09
WO2000003745A2 (en) 2000-01-27
WO2000003745A3 (en) 2000-04-20

Similar Documents

Publication Publication Date Title
CY1108542T1 (el) Εμβολιο πολυσακχαριτη για μολυνσεις απο σταφυλοκοκκο
WO2004043405A3 (en) Polysaccharide vaccine for staphylococcal infections
GT200000103A (es) Trifluorbutenos nematocidas.
DK0920421T3 (da) Isoxazolinderivater anvendelige som antimikrobielle midler
DK1075837T3 (da) Fremgangsmåde til fremstilling af vandige formuleringer til ophtalmisk anvendelse
BR0111520A (pt) Tiazina oxazolidinona usada como agente antimicrobiano
CY1106234T1 (el) Συνθεσεις για τη θepαπεια μολυνσεων staphylococcus aureus
AP2003002942A0 (en) New derivatives of oxazolidinones as bacterial agents
WO2001074788A8 (en) 2-hydroxy-mutilin carbamate derivatives for antibacterial use
AU7001996A (en) Novel derivatives of cyclodepsipeptide PF1022 substance
EP0707000A4 (en) ALDOXIME DERIVATIVE AND AGRO-HORTICULTURAL BACTERICIDE
BRPI0411534A (pt) derivados de lincomicina com atividade antimicrobiana
WO2003046007A3 (en) Treatment of micro-organism infection
NO20062629L (no) Oksazolderivater av tetrackliner
BR0316086A (pt) N-sulfonil-4-metileno amino-3-hidróxi-2-piridonas como agente microbicida
TR199901017A2 (xx) B�cek ilac� terkibi.
NZ504614A (en) Echinocandin derivatives and application as anti-fungal agents
EP1426374A4 (en) naphthyridine
EP2116552A3 (en) Peptides, derivatives thereof, process for producing the same, strain producing the same, and antiviral agent comprising the same as active ingredient
CY1110139T1 (el) Γλυκοπεπτιδικα αντιβιοτικα
BRPI0411537A (pt) derivados de lincomicina que possuem atividade antibacteriana
MX9709016A (es) 2-amino-benzoxazinonas, composiciones que las contienen y uso de las mismas.
ATE478155T1 (de) Glycopeptidantibiotika
PT1140932E (pt) Derivados de 1,8-benzonaftiridina
WO2002002088A3 (de) Anthelminthika zur verhinderung von parasitären infektionen bei mensch und tier iii